Yibala Oboma | Public Health | Best Researcher Award

Posted on by sciencefather

Assoc. Prof. Dr. Yibala Oboma | Public Health | Best Researcher Award

Senior Lecturer, Mwanza University, Tanzania

Dr. Yibala Ibor Oboma is an Associate Professor and Head of the Department of Pathology at Mwanza University, Tanzania. With over 12 years of experience in medical education and research, he specializes in histopathology, cytopathology, molecular techniques, and epidemiology. Dr. Oboma holds a PhD in Histopathology/Cytopathology from Nnamdi Azikiwe University, Nigeria, and has held academic positions at Niger Delta University, Nigeria. He is a Fellow of the West African Postgraduate College of Medical Laboratory Science and the Medical Laboratory Science Council of Nigeria. His research interests include cervical cancer, hepatotoxicity, and the therapeutic potentials of medicinal plants. Dr. Oboma is committed to advancing public health through innovative education and impactful research.

Profile

Education

Dr. Yibala Ibor Oboma’s academic journey reflects a strong foundation in medical laboratory sciences and pathology. He earned his PhD in Histopathology/Cytopathology from Nnamdi Azikiwe University in 2019, focusing on cervical human papillomavirus detection and immune response evaluation. Prior to that, he obtained a Master of Science in Histopathology/Cytology from Igbinedion University, Okada, in 2012, where his thesis addressed the prevalence of cervical HPV among women in Bayelsa State. His undergraduate degree, a Bachelor of Medical Laboratory Sciences with a specialization in Histopathology, was completed at the University of Calabar in 2006. Dr. Oboma further enhanced his expertise with certifications in Leadership and Management in Health and Epidemiology and Research from Washington University, USA, in 2018 and 2019, respectively. He is also a Fellow of the West African Postgraduate College of Medical Laboratory Science and the Medical Laboratory Science Council of Nigeria.​

Professional Experience

Dr. Yibala Ibor Oboma has a distinguished career in academia and medical laboratory science. Currently, he serves as an Associate Professor and Head of the Department of Pathology at Mwanza University, Tanzania, where he also holds the position of Associate Dean in the School of Medicine and Allied Health Sciences. Previously, he held various academic roles at Niger Delta University in Nigeria, including Associate Professor, Senior Lecturer, Lecturer I, and Lecturer II, specializing in Histopathology/Cytopathology. Dr. Oboma has also served as Principal Medical Laboratory Scientist in the Department of Anatomical Pathology at the same institution. His international experience includes a sabbatical leave at Madonna University in Nigeria. He has contributed to the academic community as an external examiner for multiple universities and has been actively involved in curriculum development and research supervision at both undergraduate and postgraduate levels.​

Research Focus

Dr. Yibala Ibor Oboma’s research focuses on the intersection of pathology, molecular biology, and public health. His work primarily addresses the epidemiology and molecular characterization of cervical cancer, particularly the role of human papillomavirus (HPV) in its pathogenesis. Dr. Oboma has also investigated the hepatoprotective effects of various medicinal plants, exploring their potential in mitigating liver damage induced by toxins such as carbon tetrachloride. His research extends to the biochemical composition of natural substances, aiming to identify therapeutic agents with antioxidant and anti-inflammatory properties. Dr. Oboma’s studies contribute to the understanding of disease mechanisms and the development of alternative treatment options, with implications for public health strategies in Africa. He has published extensively in peer-reviewed journals, with several of his works being widely cited in the scientific community.​

Publication Top Notes

  1. Toxicological studies on the aqueous leaf extract of Pavetta crassipes (K. Schum) in rodents
    Authors: MW Bariweni, OI Yibala, RI Ozolua
    Journal: Journal of Pharmacy & Pharmacognosy Research, 6(1), 1-16
    Year: 2018
    Summary: This study investigates the toxicological profile of Pavetta crassipes leaf extract in rodents, providing insights into its safety and potential therapeutic applications.​

  2. Hepatoprotective and antioxidant activities of Spondias mombin leaf and stem extracts against carbon tetrachloride-induced hepatotoxicity
    Authors: LL Nwidu, E Elmorsy, YI Oboma, WG Carter
    Journal: Journal of Taibah University Medical Sciences, 13(3), 262-271
    Year: 2018
    Summary: The research explores the hepatoprotective and antioxidant properties of Spondias mombin extracts, highlighting their potential in combating liver toxicity.​

  3. Telfairia occidentalis (Cucurbitaceae) pulp extract mitigates rifampicin-isoniazid-induced hepatotoxicity in an in vivo rat model of oxidative stress
    Authors: LL Nwidu, YI Oboma
    Journal: Journal of Integrative Medicine, 17(1), 46-56
    Year: 2019
    Summary: This study examines the protective effects of Telfairia occidentalis pulp extract against drug-induced liver damage, suggesting its therapeutic potential.​

  4. Knowledge and practice of breast cancer self-examination among female students in tertiary institutions in Nigeria
    Authors: FM Onyije, VC Zenebo, YI Oboma
    Journal: Continental Journal of Biomedical Sciences, 4, 75-82
    Year: 2010
    Summary: The paper assesses the awareness and practices related to breast cancer self-examination among Nigerian female students, emphasizing the need for educational interventions.​

  5. Hepatoprotective effect of hydromethanolic leaf extract of Musanga cecropioides (Urticaceae) on carbon tetrachloride-induced liver injury and oxidative stress
    Authors: LL Nwidu, YI Oboma, E Elmorsy, WG Carter
    Journal: Journal of Taibah University Medical Sciences, 13(4), 344-354
    Year: 2018
    Summary: This research investigates the hepatoprotective effects of Musanga cecropioides leaf extract,

Conclusion

Dr. Yibala Ibor Oboma is a strong candidate for a Best Researcher Award due to a well-rounded academic career, impactful research in cellular pathology and public health, and demonstrated commitment to capacity building across multiple African institutions. With continued efforts in grant acquisition and international publication, Dr. Oboma’s work will increasingly gain global recognition.

Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Dr. Wijdan Al-Ahmadi | Biomedicine | Best Researcher Award

Associate scientest, King Faisal specialist hospital and research center, Saudi Arabia

Dr. Wijdan Al-Ahmadi is a seasoned researcher with over 20 years of experience in biomedicine, focusing on cancer biology, immunology, and disease mechanisms. Based in Riyadh, Saudi Arabia, she is a key member of the Molecular Biomedicine Research Department at King Faisal Specialist Hospital and Research Center. Her work spans diverse fields, including inflammatory diseases and cardiovascular research. Notably, in 2023, she contributed to a groundbreaking experiment aboard the International Space Station (ISS), highlighting her ability to conduct research in extreme environments. Dr. Al-Ahmadi has demonstrated leadership through her work as an educator, mentoring students at various academic levels. Her contributions continue to push the boundaries of biomedicine, paving the way for new therapeutic strategies and personalized medicine approaches.

Profile

Education

Dr. Wijdan Al-Ahmadi holds a Ph.D. in Bioscience from Cardiff University (2015–2019), where she focused on cancer and immunology research. She also earned a B.Sc. in Biochemistry from King Saud University (1994–1998). Her academic journey has equipped her with advanced expertise in molecular biology, cancer research, and biomedical sciences. Dr. Al-Ahmadi’s educational foundation is complemented by her extensive hands-on experience in laboratory settings, which has enabled her to contribute to numerous pioneering studies. Through her formal education and continuous professional development, she has maintained a passion for unraveling disease mechanisms and enhancing health outcomes through scientific innovation.

Experience

Dr. Al-Ahmadi’s career spans over two decades in the field of biomedicine. She currently serves as an Associate Scientist at King Faisal Specialist Hospital and Research Center in Riyadh, where she leads advanced research projects in cancer biology and immunology. Prior to this, she was a Post-doctoral Fellow (2020–2023), focusing on cancer and inflammatory disease mechanisms. Dr. Al-Ahmadi’s experience includes roles as a Research Assistant (2007–2015) and a Research Technician (2002–2006), where she was deeply involved in cancer research and molecular biology assays. She has also mentored Ph.D., master’s, and undergraduate students throughout her career. Her research has had significant impact both in clinical settings and in experimental fields, including innovative studies aboard the ISS in 2023, demonstrating her versatility in different research environments.

Research Focus

Dr. Wijdan Al-Ahmadi’s research is focused on understanding the underlying mechanisms of diseases, particularly cancer, inflammatory disorders, and cardiovascular diseases. She is dedicated to uncovering how specific genetic mutations and signaling pathways contribute to disease progression, aiming to identify novel therapeutic targets for better patient outcomes. Dr. Al-Ahmadi’s work in space science is also notable, having contributed to microgravity research aboard the ISS, exploring how human physiology and disease processes respond in space. Her findings not only have applications for space health but also provide critical insights that can benefit human health on Earth. She is driven by the potential of personalized medicine and therapeutic interventions that address the root causes of disease.

Publication Top Notes

  1. Pro-atherogenic actions of signal transducer and activator of transcription 1 serine 727 phosphorylation in LDL receptor deficient mice via modulation of plaque inflammation. πŸ§¬πŸ”¬
  2. Protective effects of a unique combination of nutritionally active ingredients on risk factors and gene expression associated with atherosclerosis in C57BL/6J mice fed a high-fat diet. πŸ₯—πŸ§ͺ
  3. Posttranscriptional control of the chemokine receptor CXCR4 expression in cancer cells. πŸ§‘β€πŸ”¬πŸ¦ 
  4. miR-29a inhibition normalizes HuR over-expression and aberrant AU-rich mRNA stability in invasive cancer. πŸ§¬πŸ’‘
  5. The RNA-binding zinc-finger protein tristetraprolin regulates AU-rich mRNAs involved in breast cancer-related processes. πŸ”¬πŸ’₯
  6. Alternative polyadenylation variants of the RNA binding protein, HuR: abundance, role of AU-rich elements and auto-Regulation. πŸ§¬πŸ“Š
  7. Cloning-free regulated monitoring of reporter and gene expression. πŸ§¬πŸ§‘β€πŸ”¬
  8. RNase L downmodulation of the RNA-binding protein, HuR, and cellular growth. πŸ”¬πŸ§‘β€πŸ”¬
  9. Bioinformatics and experimental derivation of an efficient hybrid 3′ untranslated region and use in expression active linear DNA with minimum poly(A) region. πŸ’»πŸ§¬
  10. Expedient liquid chromatographic method with fluorescence detection for montelukast sodium in micro-samples of plasma. πŸ§ͺπŸ’‰

 

 

 

Baiju G Nair | Tissue engineering Award | Best Researcher Award

Posted on by sciencefatherLeave a Comment on Baiju G Nair | Tissue engineering Award | Best Researcher Award

Assoc Prof Dr Baiju G Nair | Tissue engineering Award | Best Researcher Award

Assoc Prof Dr Baiju G Nair, National Institute if technology , India

Dr. Baiju G Nair is an esteemed researcher and educator specializing in Tissue Engineering, 4D Bioprinting, and Bio-Nanotechnology. Holding a Doctorate in Bio-Nano Science Fusion Technology from Toyo University, Japan, he has made significant contributions to biomaterials and tissue regeneration. With a rich academic background from University of Calicut, India, and extensive postdoctoral experience at Riken, Japan, Dr. Nair currently serves as Associate Professor and Head of the Department of Bioscience and Engineering at NIT Calicut. His research spans nanostructures, stem cell manipulation, and advanced biomaterials for medical applications.

Publication Profile

orcid

Education πŸ“š

Dr. Baiju G Nair’s academic journey is marked by a profound commitment to scientific excellence. He earned his Doctor of Engineering in Bio-Nano Science Fusion Technology on a prestigious fellowship from the Ministry of Education, Society, Culture, and Sports (MEXT) in Japan. This advanced study was conducted at the Bio-Nano Electronics Research Centre within Toyo University’s Graduate School of New Inter-Disciplinary Sciences. Prior to this, he achieved a Master of Science in Microbial Biotechnology at the University of Calicut, Kerala, India, where he distinguished himself with top honors for academic performance and research. His foundation includes a Bachelor of Science in Zoology, Botany, and Chemistry from the same esteemed institution.

Experience

Dr. Baiju G Nair’s career is defined by a wealth of research, teaching, and administrative accomplishments. His postdoctoral experience spans prestigious roles such as SPDR Fellow and JSPS Foreign Postdoctoral Fellow at Riken’s Nanomedical Engineering Laboratory, and as a Postdoctoral Fellow at Toyo University’s BNERC. His research portfolio includes pioneering work in 3D & 4-D bioprinting, self-assembled nanostructures of proteins, RNA, and DNA, and innovative approaches in biomaterials and tissue engineering. As an educator, he has held key positions at NIT Calicut and Toyo University, fostering academic excellence. His administrative leadership includes roles as Head of Department, Vice Chairperson of CIRFL, and Innovation Ambassador, reflecting his commitment to academic and international collaborations.

Awards and Honors

Dr. Baiju G Nair’s illustrious career is adorned with prestigious awards and accolades. Notable among them are the BRIDGE JSPS Fellowship in 2022, the Young Scientist Award at the Biomedical Engineering Forum in 2017 held in Tsukuba, Japan, and the esteemed SPDR grant at Riken, Japan. His academic journey shines with distinctions such as the JSPS Foreign Postdoctoral Fellowship in 2012 and the Monbugakasho Fellowship from MEXT in 2008. His prowess in research was recognized globally with the Best Poster Presentation at NANOCON2011 in Brno, Czech Republic. Additionally, he secured the University Topper position with a Gold Medal and Rank during his master’s studies.

Research Focus

Dr. Baiju G. Nair specializes in nanotechnology platforms for biomedical applications, focusing on advanced drug delivery systems and nanostructured materials. His research spans diverse areas including 3D bioprinting, self-assembled nanostructures, and biomaterials for tissue engineering. Dr. Nair’s contributions also extend to nanomedicine innovations such as magnetic nanoparticle-based cancer therapies and nanostructured polymers for gene silencing. His expertise in nanoparticle synthesis and functionalization enhances targeted drug delivery and diagnostic tools. As a leader in the field, he continues to explore novel applications of nanotechnology in healthcare, pushing the boundaries of biomedical engineering.

Publication Top Notes

Promising bioactive compounds from the marine environment and their potential effects on various diseases πŸŒŠπŸ”¬

Implantable Microfluidic Device: An Epoch of Technology πŸ’‰πŸ”

End-Sealed High Aspect Ratio Hollow Nanotubes Encapsulating an Anticancer Drug: Torpedo-Shaped Peptidic Nanocapsules πŸ§¬πŸ’Š

Anisotropic Nano-Systems πŸ”„πŸ”¬

Discrete Nano Biomaterials πŸ§¬πŸ“š

Enhancement of synergistic gene silencing by RNA interference using branched “3-in-1” trimer siRNA πŸ§¬πŸ”¬

Nano-Films/Coated/Layered Systems 🎞️🧬

Nanocomposites 🧬🎨

Template-Assisted Formation of Nanostructured Dopamine-Modified Polymers 🧬🎨

High Density of Aligned Nanowire Treated with Polydopamine for Efficient Gene Silencing by siRNA According to Cell Membrane Perturbation πŸ§¬πŸ”¬